Optimal function of immunoisolated islets requires adequate supply of oxygen to metabolically active insulin producing beta-cells. Using mathematical modeling, we investigated the influence of the pO 2 on islet insulin secretory capacity and evaluated conditions that could lead to the development of tissue anoxia, modeled for a 300 μm islet in a 500 μm microcapsule or a 500 μm planar, slab-shaped macrocapsule. The pO 2 was used to assess the part of islets that contributed to insulin secretion. Assuming a 500 μm macrocapsule with a 300 μm islet, with oxygen consumption rate (OCR) of
100-300 nmol min
−1 mg −1 DNA, islets did not develop any necrotic core. The nonfunctional zone (with no insulin secretion if pO 2 < 0.1 mmHg) was 0.3% for human islets (OCR~100 nmol/min/mg DNA) and 35% for porcine islets (OCR 300 nmol/min/mg DNA). The OCR of the islet preparation is profoundly affected by islet size, with optimal size of <250 μm in diameter (human) or <150 μm (porcine). Our data suggest that microcapsules afford superior oxygen delivery to encapsulated islets than macrocapsules, and optimal islet function can be achieved by encapsulating multiple, small (<150 μm) islets with OCR of~100 nmol min −1 mg −1 DNA (human islets) or 200 nmol min −1 mg −1 DNA (porcine islets).
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| INTRODUCTION
Immunoisolation of pancreatic islets within bioencapsulation devices has been proposed to be an effective strategy to circumvent chronic immunosuppression in islet transplantation. Important advances have been made in the last two decades in the fields of biomaterial device design, needs for islets in the capsules and the immune responses provoked by immunoisolated pancreatic islets (Scharp & Marchetti, 2014) . Human trials are underway; temporary but reproducible islet function and survival has been reported with encapsulated pancreatic islet grafts transplanted into human diabetic patients (Jacobs-Tulleneers- Thevissen et al., 2013) .
Also, it has been shown that encapsulation may contribute to solving shortage of donor tissue as prolonged survival of xenotransplanted islet grafts has been demonstrated in both chemically induced and autoimmune diabetic rodents (Fritschy et al., 1994) , dogs (Calafiore et al., 2004) , and nonhuman primates (Dufrane, Goebbels, Saliez, Guiot, & Gianello, 2006) . There is consensus that porcine islets may serve as an inexhaustible source of islets for human diabetics (Ekser et al., 2012) .
Despite these successes and potentials of the approach, a persistent and fundamental barrier has to be overcome since graft survival varies
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While encapsulation within immunoprotective membranes can be performed in several ways (macroencapsulation, microencapsulation, or conformal coating), we will limit further discussion to macro-and microcapsules, where it has been theorized that graft oxygenation would be significantly impaired. In macroencapsulation, beta cells derived from donor islets or stem cells are enveloped in relatively large diffusion chambers with barriers that selectively exclude immune responses. In microencapsulation the islets are packaged within micronsized capsules ranging around 600um (Riccardo, 2018) . In both configurations, islets are unable to connect to host micro-vasculature as the encapsulation barrier prevents host endothelium from connecting with the islet. As a result, vital nutrients for cell survival are at a distance and their continued consumption by islet grafts results in diffusion gradients; the nutrients will be available in lower concentrations than available in the ambient interstitium. This phenomenon is more consequential in the case of oxygen (O 2 ) than other nutrients because (a) the availability of oxygen to islets depends on O 2 partial pressure (pO 2 ) rather than on O 2 saturation in the adjacent microvasculature, (b) O 2 is poorly soluble in aqueous media, and (c) islets are metabolically highly active and consume large quantities of O 2 relative to their tissue volume. Hypoxia is therefore considered to be a major contributor to the limitations in duration of survival of encapsulated islet grafts (Bloch et al., 2006) .
Although researchers have long stressed on the indispensability of adequate tissue oxygenation to ensure favorable transplant outcomes in encapsulated islet transplantation (Avgoustiniatos & Colton, 2006; Colton & Avgoustiniatos, 1991; Papas et al., 2007; Souza et al., 2011) , few studies address the severity of this issue and expound on the various factors that may influence oxygen bioavailability in encapsulated islets. To gain more insight into the severity of this problem, we investigated the influence of a number of critical factors on encapsulated islet oxygenation by using mathematical modeling algorithms.
1. The partial pressure of oxygen (pO 2 ) at the transplantation site (peritoneal cavity), which is around 40 mmHg (about 5.5% of saturation pressure) (Nöth et al., 1999) .
2. The oxygen consumption rate (OCR) of the islets which is different in human islets and porcine islets and also dependent on the quality of the islet preparation (Papas et al., 2007) .
3. Device geometry; microcapsules have a more optimal surface to volume ratio which predictably leads to a higher pO 2 than in macrocapsules.
4.
The islet load and the spatial distribution of the islets in the device.
5.
The influence of islet size.
| MATERIALS AND METHODS
The model we have developed predicts the pO 2 in the islets of different sizes and in different capsule geometries. For microcapsules, spherical geometry can minimize shear stress and friction with surrounding tissues. Also, the surface area to volume ratio of microcapsules is large enough for nutrition transportation between surrounding blood vessels and microcapsules. For macrocapsules, planar structure could provide large contact area with blood vessels to get enough oxygen supply.
The calculations below were performed for alginate-PLL capsules (Figures 1 and 2 ) and alginate-based planar macrocapsules. Since hypoxic islets do not secrete insulin in response to stimulation with glucose (Dionne, Colton, & Yarmush, 1989 , 1993 , the pO 2 will be used to indirectly measure the fraction of islets that contribute to insulin secretion.
| Modeling assumptions

| Islet size
Simulations were run for uniformly sized and spatially distributed islets. Two different islet diameters were used: 100 and 300 μm.
| Geometries
For most calculations microcapsule and macrocapsule diameter or thickness was varied to calculate the effect of the size of the device on oxygen bioavailability to the islets encapsulated within.
F I G U R E 1 Finite-element mesh and boundary conditions for a single 300 μm islet in a 500 μm alginate microcapsule. Oxygen availability at the surface (P s ) is assumed to be close to the parameter of the equilibrium pO 2 F I G U R E 2 Finite-element mesh and boundary conditions for four 100 μm islets in a 500 μm alginate microcapsule. Oxygen availability at the surface (P s ) is assumed to be close to the parameter of the equilibrium pO 2
T A B L E 1 Mathematical modeling of oxygen diffusion into a 500 μm-thick capsule using finite element analysis 
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Note: It is assumed that the pO 2 drops by 10 mmHg at the surface of the device. Utilizing smaller islets is predicted to significantly increase the oxygenated fraction and eliminates islet anoxia. It is predicted that neither increasing the number of islets encapsulated within from one to four nor reducing the gel rim thickness would significantly affect islet oxygenation or insulin release. Low OCR preparations (human islets and high quality porcine islets) are predicted to have superior islet function when compared with high OCR preparations. Abbreviation: OCR, oxygen consumption rate.
T A B L E 2 Mathematical modeling of oxygen diffusion into a 500 μm-thick slab using finite element anaysis Note: Assumptions include a gel rim thickness of 100 μm, a central gel thickness of 300 μm and that the pO 2 drops by 10 mmHg at the surface of the device. Variables include reducing the percentage of the islet/alginate layer and the thickness of the islet layer, utilizing smaller islets and increasing the number of islet monolayers. All of them are predicted to significantly increase the oxygenated fraction and insulin release and eliminate islet anoxia. Low OCR preparations (human islets and high quality porcine islets) are predicted to have superior islet function when compared with high OCR preparations. Abbreviation: OCR, oxygen consumption rate.
Other assumptions have to be made regarding geometry of the encapsulating device, thickness of islet layer, islet viability as measured by oxygen consumption ratio, concentration of alginate, surface coating, external pO 2 , presence of anoxic core, and insulin secretion.
These modeling assumption are provided in Supplement S1.
| Theoretical mathematical models and equations
The equations used for mathematical modeling is described in Supplement S2. These equations describe zero-order kinetics of the pressure diffusion and the impact of volume on oxygen partial pressure.
3 | RESULTS
| Oxygenation in transplanted islets
In addition to the internal ΔpO 2 , the consumption of O 2 inside the islet causes an external ΔpO 2 through the immunoisolation barrier and presence of any host tissue between the islet and the nearest O 2 source (usually blood vessels). The external ΔpO 2 can increase by competition of neighboring transplanted islets for O 2.
Total ΔpO 2 = Internal ΔpO 2 + External ΔpO 2 :
Thus, it is evident that the total ΔpO 2 can be much greater than equilibrium tissue pO 2 (e.g., 40 mmHg).
When that happens, anoxic cores develop inside the islets.
Oxygenation shows fraction of non-anoxic and non-hypoxic area.
Even if total ΔpO 2 less than equilibrium pO 2 and so anoxic cores are absent, the islets can be exposed to low pO 2 parameters that can negatively impact insulin secretion. At such low pO 2 parameters, insulin secretion can be affected even if no anoxic core exists. Depending on the mode of transplantation, pO 2 effects on long-term insulin secretion have to be taken into consideration.
| Effect of geometry of the device
The oxygen profiles were modeled for a 300 μm islet in a 500 μm microcapsule or in a 500 μm planar, slab shaped macrocapsule. This was done for islets with an OCR of 100 nmol min 
| Five hundred micrometer thick slab (macrocapsule)
At 25% vol/vol, 300 μm diameter islets are predicted to be oxygenated for 65-100%, depending on the islet preparation OCR/DNA.
Insulin secretion is predicted to be 25-79%, again depending on the OCR/DNA ( Table 2) . Reduction of the alginate concentration from 3 to 1% conveys a small improvement in the order of 1% (of the nonoxygen limited parameter) in both oxygenation and insulin secretion.
Reduction of the islet content in the composite layer to 20% improves oxygenation by less than 3% and also improves fractional insulin secretion, that is, the fraction of islet tissue that is able to release insulin in response to a glucose challenge, by about 5%. Fractional insulin secretion is a measure of the efficiency at which the transplanted tissue can be utilized. Bilayers (explained above) of 100 μm diameter islets perform much better and experience virtually no anoxia and smaller loss of insulin secretory capacity.
| One thousand, one hundred micrometer thick slab (macrocapsule)
This design exhibits increased oxygenation by as much as 15% of the total islet volume and smaller loss of insulin secretory capacity by about 25%. This result may be counter-intuitive as in this geometry each islet layer is oxygenated mainly from one side of the slab rather than both (Figure 3 , Table 3 ). Further analysis is required, but it is quite possible that the improvement is due to the shorter thickness of alginate between the islet and the oxygen source in this geometry (50 μm) relative to the 500 μm thick slab (100 μm).
F I G U R E 3 Schematic representation of 1,100 μm slab containing islets in two distinct 300 μm alginate-islet layers. Oxygen availability at the surface (P s ) is assumed to be close to the parameter of the equilibrium pO 2
The oxygen availability within macrocapsules (Tables 2 and 3) were different from that of microcapsules ( DNA) of the islet volume (Figure 4 ).
| Effect of islet size, spatial distribution and load in microcapsules
Next the oxygen profiles were calculated for microencapsulated islets of 100 μm diameter either as a single islet or as a group of four islets per capsule, comparing with a microcapsule containing a 300 μm islet.
With four islets of 100 μm, the islet developed no anoxic core ( Figure 5 ), in comparison to 300 μm islet ( Figure 6 ). The zone that does not contribute anymore to insulin secretion, was 51.34% for 300 μm islets ( Figure 6 ) while it was 0% for a single 100 μm islets and for a cluster of four 100 μm islets ( Figure 5) . Notably, four 100 μm islets have only 4/27 of the volume of one 300 μm islet.
| Effect of pO 2 at the transplant site
The oxygen tension at the transplant site will drop when encapsulated islets with a high OCR are implanted (Papas et al., 2005) . Therefore, the effect of lowering pO 2 was investigated on microcapsules containing four islets each ( Figure 5 ). Lowering the pO 2 to a parameter to 20 mmHg did not lead to the development of anoxic zone in microencapsulated islets ( Figure 5 ). The zone that does not contribute anymore to insulin secretion was 17%.
| Effect of the oxygen consumption rate of the islets
As the oxygen consumption rate of islets varies between species and even between isolations, we calculated the maximum islet-diameter without anoxic cores for islet preparations with an OCR varying between 50 and 900 nmol min −1 mg −1 DNA. Note that the higher parameters are just applied for modeling purposes as the maximum OCR ever observed was 460 nmol min −1 mg −1 DNA (Personal communication Papas KK). The parameters were calculated for a singleislet in a 500 μm capsule and for a pO 2 parameter of 20, 30, and 40 mmHg. As shown in Figure 7 , the OCR of the islet preparation has the most profound effect on the maximum islet-size that can be used. Islets larger that 150 μm should be avoided at OCR-parameters of 200-300 nmol min −1 mg −1 DNA, that is, typical OCR ranges for porcine islet isolations. When applying human islets with a typical T A B L E 3 Mathematical modeling of oxygen diffusion into a 1,100 μm-thick slab using finite element anaysis and neutrophils. These cells will induce profound damage to the graft in the immediate period after transplantation (Fraker, Alejandro, & Ricordi, 2002) . Thus, hypoxia not only induces direct deleterious effects on the islets in the capsules, but it will also result in a brisk immune response against the encapsulated grafts.
An improved understanding of the interplay of oxygen diffusion and consumption rate in devices is critical to improve oxygen supply to islets. Current efforts to solve the oxygen supply hurdle include engineering of islets to render them more resistant to hypoxic conditions and supply of components to enhance oxygen tensions in capsules. These include administration of organic molecules with high oxygen retention capabilities such as perfluorocarbons, silicone oils, or soybean oils (Cowley et al., 2012; Fraker et al., 2002; Papas et al., 2005) . Another approach is the supply of oxygen by an external oxygen tank (Barkai et al., 2013) .
The results of this study highlight the multitude of device and tissue parameters that influence oxygen bioavailability within islet encapsulation devices. Several published studies have demonstrated that smaller islets are more likely to have a favorable outcome after intraportal or renal subcapsular transplantation (Lehmann et al., 2007; Macgregor et al., 2006) . Two-dimensional axi-symmetric modeling predicts that encapsulated islet preparations that contain smaller islets (~100 μm) are less likely to demonstrate anoxia or suffer a reduction in insulin release when compared with large islets (~300 μm) after F I G U R E 4 pO 2 surface plot for 300 μm diameter islets encapsulated within a 500 μm-thick alginate capsule, comparing islet with OCR of 100 nmol/min/mg DNA versus 300 nmol min −1 mg −1 DNA. pO 2 varies from 40 mmHg (red) to 0.1 mmHg (white). Oxygen availability at the surface (P s ) is assumed to be close to the parameter of the equilibrium pO 2 (40 mmHg intraperitoneally)
F I G U R E 5 pO 2 surface plot for 4 × 100 μm diameter islets in a single 500 μm diameter alginate capsule. pO 2 varies from 40 mmHg (red) to 0.1 mmHg (white). Oxygen availability at the surface (P s ) is assumed to be close to the parameter of the equilibrium pO 2 (40 mmHg intraperitoneally) intraperitoneal transplantation, suggesting favorable outcomes with smaller islets.
The results of this study also suggest that islet with lower OCRs are comparatively less likely to experience anoxia and a decline in insulin release after encapsulation and intraperitoneal transplantation.
While no studies have evaluated islet OCR in encapsulated islets post-transplantation, with unencapsulated islets transplanted into portal veins or renal subscapular spaces, islet OCR has been demonstrated to be a reliable predictor of a successful outcome; the higher the OCR, the greater the chances of hyperglycemia reversal in diabetic recipients (Papas et al., 2015; Pepper et al., 2012 Modeling results also predict that oxygen bioavailability is greater within microcapsules than macrocapsules, albeit there are limitations to the scope of this conclusion as only two symmetric alginate-based planar macrocapsule constructs were evaluated. Cornolti R et al., reported that after 48 hours of in vitro culture, both micro and macroencapsulated bovine islets demonstrated no significant changes in OCR; however, only one hollow-fiber macrocapsule construct was evaluated in this study and no in vivo experiments were performed which makes it difficult to interpret the results reported (Cornolti et al., 2009 ). Our results might also explain why researchers have reported successful return to euglycemia only when either oxygen supplementation (Ludwig et al., 2012; Pedraza, Coronel, Fraker, Ricordi, & Stabler, 2012) or prevascularization (Kriz et al., 2012; Pepper et al., 2015) was employed with macrocapsule devices transplanted into diabetic recipients. However, results obtained with microcapsules have been far more encouraging (Hals et al., 2013; Pareta et al., 2014; Yang et al., 2016) .
| Model validation
In vivo study has shown presence of oxygen gradient in the capsule.
However, in vitro validation would be necessary to measure oxygen gradient within islets. Also, since an oxygen sink can significantly change pO 2 at the surface of each device, pO 2 need to be tracked for device with oxygen sink. The development of implantable oxygen sensors would enable determination of tissue pO 2 at various implant sites, thus greatly increasing the predictive accuracy of our model (Weidling, Sameni, Lakey, & Botvinick, 2014) .
| CONCLUSIONS
Encapsulated islet oxygenation is a serious issue. Modeling is a powerful tool to evaluate designs before experiments are carried out. Modeling is F I G U R E 6 pO 2 surface plot for 300 μm diameter islets encapsulated within a 500 μm-thick alginate capsule. pO 2 varies from 40 mmHg (red) to 0.1 mmHg (white). Oxygen availability at the surface (P s ) is assumed to be close to the parameter of the equilibrium pO 2 (40 mmHg intraperitoneally) F I G U R E 7 Effect of islet preparation OCR on encapsulated islet oxygenation. The graph predicts the "maximum allowable islet diameter without an anoxic core" for human and porcine islet preparations encapsulated within a 500 μm diameter capsule assuming a ratio of one 300 μm diameter islet per capsule. If the pO 2 at the capsule surface is lowered, the "maximum allowable islet diameter without an anoxic core" reduces correspondingly. OCR, oxygen consumption rate limited by the accuracy of the assumptions and parameters used, but it is reliable as long as measurements for parameters that are preparationspecific (e.g., OCR) or are not well characterized (e.g., equilibrium pO 2 at transplantation site before and after transplantation) taken into account to make specific predictions and accurately evaluate biomaterial device design to improve transplantation outcomes. 
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